Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach

被引:17
作者
Andreano, Anita [1 ,2 ]
Rebora, Paola [1 ]
Valsecchi, Maria Grazia [1 ]
Russo, Antonio Giampiero [2 ]
机构
[1] Univ Milano Bicocca, Sch Med & Surg, Ctr Biostat Clin Epidemiol, Via Cadore 48, I-20900 Monza, Italy
[2] Agcy Hlth Protect Prov Milan, Epidemiol Unit, Milan, Italy
关键词
Breast cancer care; Adherence to guidelines; Survival; Causal inference; Administrative health databases; Process indicators; COMORBIDITY INDEX; INDICATORS; CHEMOTHERAPY; ASSOCIATION; PERFORMANCE; MANAGEMENT; MORTALITY; DIAGRAMS; OUTCOMES; THERAPY;
D O I
10.1007/s10549-017-4210-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose There is a lack of real-world studies evaluating the impact on survival of an evidence-based pathway of care in breast cancer. The aim of this work is to investigate the effect of adherence to guidelines on long-term survival for a cohort of Italian breast cancer patients. Methods The cohort included incident female breast cancer cases (2007-12), from the registry of the Milan province (Italy), not metastatic at diagnosis and receiving primary surgery. We selected sets of indicators, according to patient and tumor characteristics. We then defined the pathway of care as adherent to guidelines if it fulfilled at least 80% of the indicators. Indicators were measured using different administrative health databases linked on a unique key. A causal inference approach was used, drawing a directed acyclic graph and fitting an inverse probability weighted marginal structural model, accounting for patient's demographic, socioeconomic and tumor characteristics. Results The analysis included 6333 patients, 69% of them were classified as having an adherent care. Mean age was 61 years (standard deviation, 13.6 years) and half of the patients were in Stage I (50%) at diagnosis. Median follow-up time was 5.6 years. Overall, 5-year survival was 90% (95% CI, 89-91%). The estimated risk of death was 30% lower for patients with adherent than nonadherent care (hazard ratio [HR], 0.66; 95% CI, 0.55-0.77). Conclusions Our study confirms, in real-world care, the impact on survival of receiving a care pathway adherent to guidelines in non-metastatic breast cancer patients.
引用
收藏
页码:119 / 131
页数:13
相关论文
共 50 条
  • [21] Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study
    Peipei Liu
    Úna C. McMenamin
    Andrew D. Spence
    Brian T. Johnston
    Helen G. Coleman
    Chris R. Cardwell
    BMC Cancer, 19
  • [22] The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach
    Guerreiro, Teresa
    Mayer, Alexandra
    Aguiar, Pedro
    Araujo, Antonio
    Nunes, Carla
    ANNALS OF GLOBAL HEALTH, 2023, 89 (01):
  • [23] Risk and Survival of Third Primary Cancers in a Population-Based Cohort of Breast Cancer Patients
    Morais, Samantha
    Goncalves, Elisabete
    Fontes, Filipa
    Rodrigues, Jessica
    Calisto, Rita
    Bento, Maria Jose
    Lunet, Nuno
    BREAST CARE, 2022, 17 (04) : 349 - 354
  • [24] β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis
    Lofling, L. Lukas
    Stoer, Nathalie C.
    Sloan, Erica K.
    Chang, Aeson
    Gandini, Sara
    Ursin, Giske
    Botteri, Edoardo
    BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 1086 - 1096
  • [25] Development and validation of a nomogram for predicting the overall survival of prostate cancer patients: a large population-based cohort study
    Zhou, Zheng
    Pu, Jinxian
    Wei, Xuedong
    Huang, Yuhua
    Lin, Yuxin
    Wang, Liangliang
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, : 1325 - 1335
  • [26] Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study
    Karasneh, Reema A.
    Murray, Liam J.
    Mc Menamin, Una C.
    Hughes, Carmel M.
    Cardwell, Chris R.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 661 - 669
  • [27] Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
    D M Fraser
    F M Sullivan
    A M Thompson
    C McCowan
    British Journal of Cancer, 2014, 111 : 623 - 627
  • [28] Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study
    Reema A. Karasneh
    Liam J. Murray
    Úna C. Mc Menamin
    Carmel M. Hughes
    Chris R. Cardwell
    Breast Cancer Research and Treatment, 2015, 151 : 661 - 669
  • [29] Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
    de Glas, Nienke
    Bastiaannet, Esther
    de Boer, Anna
    Siesling, Sabine
    Liefers, Gerrit-Jan
    Portielje, Johanneke
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) : 141 - 149
  • [30] Prediction of conditional survival in esophageal cancer in a population-based cohort study
    Xie, Shao-Hua
    Santoni, Giola
    Bottai, Matteo
    Gottlieb-Vedi, Eivind
    Lagergren, Pernilla
    Lagergren, Jesper
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (05) : 1141 - 1148